Publication | Closed Access

Nanocarrier-Based Combination Chemotherapy for Resistant Tumor: Development, Characterization, and Ex Vivo Cytotoxicity Assessment

Nanocarrier-based Combination ChemotherapyNanomedicineOncologyNanotherapeuticsHealth SciencesPolymer-drug ConjugateMedicineTumor TargetingChemodynamic TherapyMetronomic ChemotherapyAnti-cancer AgentRadiation OncologyPharmacologyCancer ChemotherapyCancer ResearchResistant Tumor